RBC Life Sciences Reports Significant Increase in Sales and Earnings

Trading Markets.com:

"RBC Life Sciences, Inc. today reported a 45 percent increase in net sales to $7,857,000 in the third quarter of 2007, compared to net sales of $5,405,000 in the same period last year. The Company's net earnings increased more than 700 percent in the third quarter of 2007 to $672,000, or $0.03 per share, compared to net earnings of $80,000, or $0.00 per share, in the 2006 third quarter.

RBC's net sales for the first nine months of 2007 increased 24 percent to $20,397,000 compared to net sales of $16,416,000 in the same period last year. For this nine-month period, the Company's net earnings increased more than 300 percent to $1,507,000, or $0.07 per share, compared to net earnings of $335,000, or $0.01 per share, in the same period last year.

Clinton Howard, Chairman and CEO of RBC Life Sciences, said, 'The significant increase in net earnings this year has resulted from strong sales growth in both our nutritional supplements segment and our medical products segment. The growth of our international nutritional supplement sales under license agreements has been particularly strong. Also, comparative earnings for the first nine months of last year were lower due to expenses associated with opening an office in Asia in 2006.'"